Aarti Industries Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹19.1K Cr
Steady volume growth is expected, supported by capacity expansion and deeper market penetration. - Despite short-term export headwinds due to the West Asia conflict, underlying demand remains robust across most end markets. - Fuel additives capacity expanded to 360 KTPA and is expected to reach high utilization soon, with potential to increase further post-stabilization. - Non-energy segments like polymers and agrochemicals are anticipated to recover volume in Q2 after seasonal and pricing pressures. - New platforms like battery chemicals and defense applications are being explored based on capability and return profiles. - JV operations (e.g., Augene Chemicals) are ramping up, contributing to future revenue growth. - FY27 capex is on track at Rs. Aarti Industries targets EBITDA of INR 1,800 crore by FY28, including contributions from the Augene JV.
From Aarti Industries's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Price
₹538
Market Cap
₹19.1K Cr
P/E Ratio
36.6
Revenue Rank
Margin Rank
How does Aarti Industries rank in Chemicals & Petrochemicals?
Compare Aarti Industries against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Aarti Industries — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.2K Cr, net profit ₹137 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 3- →Steady volume growth is expected, supported by capacity expansion and deeper market penetration.
- →Despite short-term export headwinds due to the West Asia conflict, underlying demand remains robust across most end markets.
- →Fuel additives capacity expanded to 360 KTPA and is expected to reach high utilization soon, with potential to increase further post-stabilization.
- →Non-energy segments like polymers and agrochemicals are anticipated to recover volume in Q2 after seasonal and pricing pressures.
- →New platforms like battery chemicals and defense applications are being explored based on capability and return profiles.
- →JV operations (e.g., Augene Chemicals) are ramping up, contributing to future revenue growth.
- →FY27 capex is on track at Rs. 700-800 crore with reduced intensity expected after major expansions complete.
- →FY28 target EBITDA of Rs. 1800 crore includes contribution from JV operations, reflecting confidence in growth trajectory.
📈 Profitability & Margins
Rank 3- →Aarti Industries targets EBITDA of INR 1,800 crore by FY28, including contributions from the Augene JV.
- →Growth is expected from volume recovery and capacity expansions, particularly in fuel additives (360 KTPA capacity).
- →Zone IV project, despite 3-6 months delay, is expected to commission in phases with ramp-up over FY28 and FY29.
- →Non-energy segments like polymers and pharma show stable to strong demand; dyes and pigments likely to recover.
- →Margin trajectory may normalize post volatile raw material and forex impacts; business runs on absolute delta margins.
- →Future capex will focus on high-growth, high-return niche projects with lower overall CAPEX intensity from FY28.
- →New markets and products (battery chemicals, defense) selected based on competitiveness, scalability, and returns.
- →JVs and downstream initiatives (Augene, Re Sustainability) expected to add value from FY27 onwards.
🏗️ Capital Expenditure Plans
Yes- →Zone IV project expansion is ongoing with 3-6 months delay due to labor and war-related issues; commissioning is phased over FY27 with ramp-up in FY28 and FY29.
- →FY27 CAPEX is on track within Rs. 700-800 crore range, with Rs. 180 crore deployed in Q1FY27.
- →Future capital deployment will focus on high-growth, high-return niche projects, reducing CAPEX intensity starting FY28.
- →Debottlenecking of DCB capacity to 140 KTPA planned, supported by demand for PDCB and downstream products.
- →JV with Superform Chemistries (Augene Chemicals) is on track for commissioning in Q2FY27, focusing on specialty chemicals.
- →Plastic recycling initiative with Re Sustainability (Aarti Circularity) slated for commissioning in second half of FY27, emphasizing ESG and circularity.
- →Expansion through subsidiaries in UAE, UK, USA progressing; a new subsidiary planned in China to enhance market reach and sourcing efficiency.
💰 Fundraising & Capital Structure
No information- →No explicit mention of any current or future fundraising through debt or equity in the provided transcript.
- →The company discussed ongoing and planned capital expenditures (CAPEX) for FY27 in the range of Rs. 700 to 800 crore.
- →Major expansion programs are nearing completion, and CAPEX intensity is expected to reduce starting next year.
- →Future capital deployment will focus on high-growth, high-return niche projects.
- →No direct reference to raising funds via debt or equity was stated during the call or in the management's discussion.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Aarti Industries Q1 FY27 results?
Steady volume growth is expected, supported by capacity expansion and deeper market penetration. - Despite short-term export headwinds due to the West Asia conflict, underlying demand remains robust across most end markets. - Fuel additives capacity expanded to 360 KTPA and is expected to reach high utilization soon, with potential to increase further post-stabilization. - Non-energy segments like polymers and agrochemicals are anticipated to recover volume in Q2 after seasonal and pricing pressures. - New platforms like battery chemicals and defense applications are being explored based on capability and return profiles. - JV operations (e.g., Augene Chemicals) are ramping up, contributing to future revenue growth. - FY27 capex is on track at Rs. Aarti Industries targets EBITDA of INR 1,800 crore by FY28, including contributions from the Augene JV.
What is Aarti Industries share price analysis?
Aarti Industries currently shows a below-average growth signal. The stock trades at a P/E of 36.6 with a market cap of ₹19,123 Cr. Investors should review the full earnings analysis for detailed insights.
Is Aarti Industries planning capital expenditure?
Zone IV project expansion is ongoing with 3-6 months delay due to labor and war-related issues; commissioning is phased over FY27 with ramp-up in FY28 and FY29.
Keep Aarti Industries on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.